Management of post-infarction angina

Area of Science:

• Cardiology
• Internal Medicine

Background:

• Post-infarction angina is ischemic chest pain occurring ≥24 hours after acute myocardial infarction (MI).
• It affects 10-15% of patients, particularly those with non Q-wave anterior MIs.
• This condition often indicates a poor long-term prognosis due to ischemia within or distant from the infarct zone.

Purpose of the Study:

• To outline the pathogenesis and management strategies for post-infarction angina.
• To highlight the importance of addressing factors increasing myocardial demand.
• To review current and investigational therapeutic options.

Main Methods:

• Review of pathogenesis involving platelet aggregation, coronary vasospasm, and plaque rupture.
• Discussion of initial management including correction of heart failure and arrhythmias.
• Evaluation of medical therapies: beta-blockers, calcium channel blockers, nitrates, and antiplatelet agents.
• Consideration of advanced interventions: heparin, thrombolytics, intra-aortic balloon pump, and coronary angiography.

Main Results:

• Medical therapy includes beta-blockers, calcium channel blockers, and nitrates as first-line treatments.
• The role of heparin remains controversial but is used clinically.
• Thrombolytic agents may aid stabilization and facilitate elective revascularization.
• Aspirin demonstrates long-term benefits in unstable angina management.

Conclusions:

• Post-infarction angina necessitates prompt identification and management of contributing factors.
• Medical therapy is the initial approach, with revascularization (angioplasty or bypass grafting) reserved for non-responsive patients.
• Early coronary angiography and potential revascularization are crucial for selected patients.